Insulin Drugs Global Market Report 2022 – By Product Type (Prandial Insulins, Basal Insulins, Premixed Insulins, Other Insulins), By Application (Type II Diabetes, Type I Diabetes, Gestational Diabetes, Prediabetes), By Drug Classification (Branded Drugs, Generic Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drugs Stores) – Market Size, Trends, And Global Forecast 2022-2026

Starting Price : $5000.00 | Pages : 175 | Published : March 2022 | SKU CODE : 7264 | Delivery Time: 2-3 business days | Format :


The insulin drugs market consists of manufacturers’ sales of insulin drugs and types of Insulin by entities (organizations, sole traders and partnerships) which are used to treat diabetes. Insulin is a medication prescribed to treat type 1 diabetes and type 2 diabetes mellitus. There are several types, preparations, and dosage amount of insulin. Insulin is a hormone that is produced naturally in our bodies. Its main role is to allow cells throughout the body to uptake glucose (sugar) and convert it into a form that can be used by these cells for energy. The market covered in this report does not include non-insulin drugs and other antidiabetic drugs or medicine.

The main product types of insulin drugs are prandial insulins, basal insulins, premixed insulins, other insulins. A meal is referred to as a prandial. Postprandial (from post prandium) refers to the time after a meal, whereas preprandial refers to the time before a meal. The drugs are classified into branded drugs and generic drugs that are distributed by hospital pharmacies, retail pharmacies, drugs stores, others. The various application include type II diabetes, type I diabetes, gestational diabetes, and prediabetes.

The global insulin drugs market size is expected to grow from $28.82 in billion 2021 to $32.51 billion in 2022 at a compound annual growth rate (CAGR) of 12.8%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global insulin drug market size is expected to reach $49.71 billion in 2026 at a CAGR of 11.2%.

Changing lifestyles are leading to a higher prevalence of diabetes. This is expected to drive the demand for diabetes drugs during the forecast period. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of diabetes. According to a study, there was a high prevalence of diabetes in people with sedentary lifestyles. Additionally, people suffering from obesity are up to 80 times more likely to develop type 2 diabetes. According to a World Health Organization (WHO) report, 74% of men and 64% of women in the UK, for instance, are expected to be overweight by 2030. These factors are expected to increase the patient pool of diabetes, thereby likely to drive the diabetes therapies market during the forecast period.

High costs and long payback periods for investment in new diabetes drugs negatively impacted the market during the forecast period. The costs for drug approval processes that include multiple phases of clinical trials and screening processes with regulatory bodies such as the US FDA are very high. According to a study published in the journal JAMA, the cost of bringing a new drug from its conception to shelves was about $2.8 billion in 2020. These high costs and uncertainty regarding return on investments for drug development limited the investments by pharmaceutical companies in the development of new diabetic drugs, thus limiting the growth of the market during the historic period.

There is an increased trend of mergers and acquisitions for the new formulations in Insulin market and the companies are investing in development of new medicines in Insulin drugs market. For example, researchers at Lund University Diabetes Centre in Sweden, worked on CRISPR, a genome modification tool. This resulted in turning off of one of the genes which was responsible for causing diabetes. This effectively decreased beta cell death and increased insulin production in the pancreas. Insulin maker, Novo Nordisk has developed a diabetes pill and planned to launch it in India by February 2022. This pill belongs to a blockbuster class of drugs, glucagon like peptide-1 (GLP-1s) that stimulate insulin production. The new drug is expected to generate about $5 billion in annual sales.

In September 2019, Vertex Pharmaceuticals, an America based Biopharmaceutical company acquired Semma Therapeutics for $950 million. Through this acquisition Vertex has turned to potentially curative technologies like CRISPR genome editing and synthetic messenger RNA for its next generation of products. Semma Therapeutics, a USA based company that develops transformative therapies for Type 1 diabetes patients.

Major players in the insulin drugs market are Apidra, Eli Lilly, Humalog, Humulin, Insuman, Lantus, Levemir, Novo Nordisk, Novomix, NovoRapid/Novolog, Actrapid, Admelog, Novolin/Actrapid/Insulatard, Ryzodeg, Sanofi, Soliqua/Suliqua, Toujeo, Tresiba and Xultophy.

North America was the largest region in the insulin drugs market in 2021. The Middle East is expected to be the fastest growing region in the global insulin drugs market during the forecast period. The regions covered in the global insulin drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The global insulin drug market is segmented -

1) By Product Type: Prandial Insulins, Basal Insulins, Premixed Insulins, Others

2) By Application: Type II Diabetes, Type I Diabetes, Gestational Diabetes, Prediabetes

3) By Drug Classification: Branded Drugs, Generic Drugs

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drugs Stores, Others

    Table Of Contents

    1. Executive Summary

    2. Insulin Drugs Market Characteristics

    3. Insulin Drugs Market Trends And Strategies

    4. Impact Of COVID-19 On Insulin Drugs

    5. Insulin Drugs Market Size And Growth

    5.1. Global Insulin Drugs Historic Market, 2016-2021, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Insulin Drugs Forecast Market, 2021-2026F, 2031F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Insulin Drugs Market Segmentation

    6.1. Global Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Prandial Insulins

    Basal Insulins

    Premixed Insulins

    Other Insulins

    6.2. Global Insulin Drugs Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Type II Diabetes

    Type I Diabetes

    Gestational Diabetes

    Prediabetes

    6.3. Global Insulin Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Branded Drugs

    Generic Drugs

    6.4. Global Insulin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies

    Drugs Stores

    Others

    7. Insulin Drugs Market Regional And Country Analysis

    7.1. Global Insulin Drugs Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    7.2. Global Insulin Drugs Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8. Asia-Pacific Insulin Drugs Market

    8.1. Asia-Pacific Insulin Drugs Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    9. China Insulin Drugs Market

    9.1. China Insulin Drugs Market Overview

    9.2. China Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    10. India Insulin Drugs Market

    10.1. India Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11. Japan Insulin Drugs Market

    11.1. Japan Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12. Australia Insulin Drugs Market

    12.1. Australia Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13. Indonesia Insulin Drugs Market

    13.1. Indonesia Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14. South Korea Insulin Drugs Market

    14.1. South Korea Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15. Western Europe Insulin Drugs Market

    15.1. Western Europe Insulin Drugs Market Overview

    15.2. Western Europe Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16. UK Insulin Drugs Market

    16.1. UK Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17. Germany Insulin Drugs Market

    17.1. Germany Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18. France Insulin Drugs Market

    18.3. France Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19. Eastern Europe Insulin Drugs Market

    19.1. Eastern Europe Insulin Drugs Market Overview

    19.2. Eastern Europe Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20. Russia Insulin Drugs Market

    20.1. Russia Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21. North America Insulin Drugs Market

    21.1. North America Insulin Drugs Market Overview

    21.2. North America Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22. USA Insulin Drugs Market

    22.1. USA Insulin Drugs Market Overview

    22.2. USA Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23. South America Insulin Drugs Market

    23.1. South America Insulin Drugs Market Overview

    23.2. South America Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24. Brazil Insulin Drugs Market

    24.1. Brazil Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25. Middle East Insulin Drugs Market

    25.1. Middle East Insulin Drugs Market Overview

    25.2. Middle East Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26. Africa Insulin Drugs Market

    26.1. Africa Insulin Drugs Market Overview

    26.2. Africa Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    27. Insulin Drugs Market Competitive Landscape And Company Profiles

    27.1. Insulin Drugs Market Competitive Landscape

    27.2. Insulin Drugs Market Company Profiles

    27.2.1. Apidra

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Eli Lilly

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Humalog

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Humulin

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Insuman

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Insulin Drugs Pipeline Analysis

    29. Key Mergers And Acquisitions In The Insulin Drugs Market

    30. Insulin Drugs Market Future Outlook and Potential Analysis

    31. Appendix

    31.1. Abbreviations

    31.2. Currencies

    31.3. Research Inquiries

    31.4. The Business Research Company

    31.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Table 3: Global Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 4: Global Insulin Drugs Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 5: Global Insulin Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 6: Global Insulin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7: Global Insulin Drugs Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8: Global Insulin Drugs Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9: Asia-Pacific, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10: China, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11: India, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 12: Japan, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 13: Australia, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 14: Indonesia, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 15: South Korea, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 16: Western Europe, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 17: UK, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 18: Germany, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 19: France, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 20: Eastern Europe, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 21: Russia, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 22: North America, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 23: USA, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 24: South America, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 25: Brazil, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 26: Middle East, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 27: Africa, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 28: Apidra Financial Performance
  • Table 29: Eli Lilly Financial Performance
  • Table 30: Humalog Financial Performance
  • Table 31: Humulin Financial Performance
  • Table 32: Insuman Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Figure 3: Global Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 4: Global Insulin Drugs Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 5: Global Insulin Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 6: Global Insulin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7: Global Insulin Drugs Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8: Global Insulin Drugs Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9: Asia-Pacific, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10: China, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11: India, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 12: Japan, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 13: Australia, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 14: Indonesia, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 15: South Korea, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 16: Western Europe, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 17: UK, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 18: Germany, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 19: France, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 20: Eastern Europe, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 21: Russia, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 22: North America, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 23: USA, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 24: South America, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 25: Brazil, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 26: Middle East, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 27: Africa, Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 28: Apidra Financial Performance
  • Figure 29: Eli Lilly Financial Performance
  • Figure 30: Humalog Financial Performance
  • Figure 31: Humulin Financial Performance
  • Figure 32: Insuman Financial Performance
Global Contract Research And Manufacturing Services (CRAMS) Market Size, Forecasts, And Opportunities – Includes CRAMS Market Overview
Global Anti-Infective Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cell and Gene Therapy Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Pharmaceutical Drugs And Biologics Logistics Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Pharmaceutical Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Microbiome Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global G-CSF (Granulocyte Colony Stimulating Factors) Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Blood Glucose Meters Global Market Report 2022 – By Product type (Electrode Type Blood Glucose Meter, Photoelectric Blood Glucose Meter), By End User (Hospitals, Home Care), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2022 – By Type (Pens, Injectors And Pumps, Syringes), By End Users (Hospitals, Homecare, Other End Users), By Pens (Reusable, Disposable), By Pumps (Tubed Pumps, Tubeless Pumps) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Diabetes Care Devices Global Market Report 2022 – By Type (Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters), By End User (Hospitals And Clinics, Diagnostic Laboratories, Other End Users), By Type of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Smart Insulin Pens Global Market Report 2022 – By Type (First Generation Pens, Second Generation Pens (Bluetooth Enabled, USB Connected)), By End User (Hospitals & Clinics, Ambulatory Surgical Centres, Home Care Settings), By Usability (Prefilled, Reusable), By Application (Type 1 Diabetes, Type 2 Diabetes) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Autoinjectors Global Market Report 2022 – By Type (Disposable Autoinjectors, Reusable Autoinjectors), By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis), By Route Of Administration (Subcutaneous, Intramuscular), By Distribution Channel (Online Retailer, Pharmacy), By End User (Home Care Settings, Hospitals And Clinics) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Digital Diabetes Management Global Market Report 2022 – By Product & Service (Devices, Application, Data Management Software & Platforms, Services), By Device Type (Handheld Devices, Wearable Devices), By End User (Self/Home Healthcare, Hospitals & Specialty Diabetes Clinics) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Biosimilar Hormones Global Market Report 2022 – By Type (Teriparatide Biosimilars, Follitropin Alfa Biosimilars, Insulin Biosimilars, Somatropin Biosimilars), By Application (Research & Biotechnology, Diagnostics, Biocatalysts, Therapeutics), By Distribution Channel (Hospital And Retail Pharmacy, Online Pharmacy/epharmacy, Speciality Clinics) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Biosimilars Global Market Report 2022 – By Product (Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins), By Types (Human Growth Hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor), By Application (Oncology, Chronic and Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases) – Market Size, Trends, And Global Forecast 2022-2026
View Report